Cargando…

Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives

Our recent tissue cross-linking studies using formaldehyde releasers (FARs) suggest that corneal and scleral tissue strengthening may be possible without using ultraviolet irradiation or epithelial removal, two requirements for the photochemical method in widespread clinical use. Thus, the present s...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaoka, Anna, Cao, Kerry, Oste, Eric M., Nagasaki, Takayuki, Paik, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500889/
https://www.ncbi.nlm.nih.gov/pubmed/30971499
http://dx.doi.org/10.1042/BSR20182392
_version_ 1783416028855795712
author Takaoka, Anna
Cao, Kerry
Oste, Eric M.
Nagasaki, Takayuki
Paik, David C.
author_facet Takaoka, Anna
Cao, Kerry
Oste, Eric M.
Nagasaki, Takayuki
Paik, David C.
author_sort Takaoka, Anna
collection PubMed
description Our recent tissue cross-linking studies using formaldehyde releasers (FARs) suggest that corneal and scleral tissue strengthening may be possible without using ultraviolet irradiation or epithelial removal, two requirements for the photochemical method in widespread clinical use. Thus, the present study was carried out in order to better understand these potential therapeutic solutions by studying the effects of concentration, pH, buffer, time, and tissue reactivity on formaldehyde release of these FARs. Three FARs, sodium hydroxymethyl glycinate (SMG), DMDM, and diazolidinyl urea (DAU) were studied using a chromotropic acid colorimetric FA assay. The effects of concentration, pH, and buffer were studied as well as the addition of corneal and scleral tissues. The main determinant of release was found to be dilution factor (concentration) in which maximal release was noted at the lowest concentrations studied (submillimolar). In time dependent studies, after 60 min, FA levels decreased by 38% for SMG, 30% for DMDM, and 19% for DAU with corneal tissue added; and by 40% for SMG, 40% for DMDM, and 15% for DAU with scleral tissue added. We conclude that concentration (dilution factor) was found to be the most important parameter governing the percent of FA released.
format Online
Article
Text
id pubmed-6500889
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-65008892019-06-11 Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives Takaoka, Anna Cao, Kerry Oste, Eric M. Nagasaki, Takayuki Paik, David C. Biosci Rep Research Articles Our recent tissue cross-linking studies using formaldehyde releasers (FARs) suggest that corneal and scleral tissue strengthening may be possible without using ultraviolet irradiation or epithelial removal, two requirements for the photochemical method in widespread clinical use. Thus, the present study was carried out in order to better understand these potential therapeutic solutions by studying the effects of concentration, pH, buffer, time, and tissue reactivity on formaldehyde release of these FARs. Three FARs, sodium hydroxymethyl glycinate (SMG), DMDM, and diazolidinyl urea (DAU) were studied using a chromotropic acid colorimetric FA assay. The effects of concentration, pH, and buffer were studied as well as the addition of corneal and scleral tissues. The main determinant of release was found to be dilution factor (concentration) in which maximal release was noted at the lowest concentrations studied (submillimolar). In time dependent studies, after 60 min, FA levels decreased by 38% for SMG, 30% for DMDM, and 19% for DAU with corneal tissue added; and by 40% for SMG, 40% for DMDM, and 15% for DAU with scleral tissue added. We conclude that concentration (dilution factor) was found to be the most important parameter governing the percent of FA released. Portland Press Ltd. 2019-05-03 /pmc/articles/PMC6500889/ /pubmed/30971499 http://dx.doi.org/10.1042/BSR20182392 Text en © 2019 The Author(s). http://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Takaoka, Anna
Cao, Kerry
Oste, Eric M.
Nagasaki, Takayuki
Paik, David C.
Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title_full Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title_fullStr Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title_full_unstemmed Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title_short Topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
title_sort topical therapeutic corneal and scleral tissue cross-linking solutions: in vitro formaldehyde release studies using cosmetic preservatives
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500889/
https://www.ncbi.nlm.nih.gov/pubmed/30971499
http://dx.doi.org/10.1042/BSR20182392
work_keys_str_mv AT takaokaanna topicaltherapeuticcornealandscleraltissuecrosslinkingsolutionsinvitroformaldehydereleasestudiesusingcosmeticpreservatives
AT caokerry topicaltherapeuticcornealandscleraltissuecrosslinkingsolutionsinvitroformaldehydereleasestudiesusingcosmeticpreservatives
AT osteericm topicaltherapeuticcornealandscleraltissuecrosslinkingsolutionsinvitroformaldehydereleasestudiesusingcosmeticpreservatives
AT nagasakitakayuki topicaltherapeuticcornealandscleraltissuecrosslinkingsolutionsinvitroformaldehydereleasestudiesusingcosmeticpreservatives
AT paikdavidc topicaltherapeuticcornealandscleraltissuecrosslinkingsolutionsinvitroformaldehydereleasestudiesusingcosmeticpreservatives